Selected article for: "acute respiratory and low pathogenicity"
Author: Sessa, Maria; Rizzi, Marco; Gerevini, Simonetta
Title: Background
  • Cord-id: 02o0y8zh
  • Document date: 2021_3_18
    • ID: 02o0y8zh
    Snippet: Human coronaviruses, first characterized in the 1960s, are responsible for a substantial proportion of upper respiratory tract infections in children, with occasional cases of pneumonia in infants and young adults; for a few decades since their first identification, their pathogenicity has been considered to be low; non-respiratory localizations of the disease, including neurological complications, have been described as uncommon events [1]. In the new millennium, new more virulent coronaviruses
    Document: Human coronaviruses, first characterized in the 1960s, are responsible for a substantial proportion of upper respiratory tract infections in children, with occasional cases of pneumonia in infants and young adults; for a few decades since their first identification, their pathogenicity has been considered to be low; non-respiratory localizations of the disease, including neurological complications, have been described as uncommon events [1]. In the new millennium, new more virulent coronaviruses made their appearance in humans SARS-CoV, causing the Severe Acute Respiratory Syndrome (2002–2004) and MERS-CoV, causing the Middle Eastern Respiratory Syndrome (2012–ongoing); also SARS-CoV and MERS-CoV were mostly associated to respiratory disease, but different organs and body systems could be involved, including the Central Nervous System [2], as recently summarized by Verstrepen et al. [3].

    Search related documents:
    Co phrase search for related documents
    • accurate characteristic and acute organ respiratory distress syndrome: 1
    • accurate characteristic and acute organ respiratory distress syndrome failure: 1
    • accurate characteristic and acute respiratory: 1
    • active disease and acute adem: 1
    • active disease and acute infarction: 1, 2
    • active disease and acute ischemic stroke: 1, 2
    • active disease and acute phase: 1, 2, 3, 4, 5
    • active disease and acute phase therapy: 1
    • active disease and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infarction and additional case: 1
    • acute infarction and additional case report: 1
    • acute respiratory and additional case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19